Items Tagged ‘News Tips and Features’


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s News Tips And Features News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.

April 4, 2019

CD40 Combination Therapy Can Shrink Pancreatic Tumors

By Anonymous User anonymous_user_10987

A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients – 20 out of 24 as of an interim analysis of the phase 1b trial data. The early findings provide hope that this strategy involving a CD40 antibody, a checkpoint inhibitor, and standard-of-care chemotherapy could […]

View full entry

Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer


March 18, 2019

Lynparza Delays Progression of BRCA-mutated Metastatic Pancreatic Cancer

By Anonymous User anonymous_user_10987

Lynparza (olaparib) improves progression-free survival (PFS) when used to treat BRCA-mutated pancreatic cancer and appears to represent a new treatment option for this hard to treat cancer. (1-4) About BRCA Mutated Pancreatic Cancer Pancreatic cancer has the worst survival rate of the most common cancers and less than seven percent of patients survive more than […]

View full entry

Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer


March 8, 2019

FDA Approves Lonsurf® for Treatment of Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

By Anonymous User anonymous_user_10987

The United States Food and Drug Administration (FDA) has approved Lonsurf® (trifluridine/tipiracil)) as a treatment for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy. About Lonsurf Lonsurf consists of […]

View full entry

Tags: Gastric Cancer, News Tips and Features, News Tips and Features Other


February 28, 2019

Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer

By Anonymous User anonymous_user_10987

Results from the trial showed a significant and clinically-meaningful improvement in progression-free survival (PFS) with Lynparza (olaparib) for the treatment of BRCA-mutated pancreatic cancer. POLO is a randomised, double-blinded, placebo-controlled trial exploring the efficacy of Lynparza tablets as 1st-line maintenance monotherapy in patients with germline BRCA-mutated (gBRCAm) metastatic adenocarcinoma of the pancreas (pancreatic cancer) whose […]

View full entry

Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer


November 13, 2018

Keytruda Immunotherapy for Treatment of Liver Cancer

By Anonymous User anonymous_user_10987

According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib), (1) and has not been approved by the US for use in patients with liver cancer. Keytruda was approved as a […]

View full entry

Tags: Liver Cancer, News Tips and Features, News Tips and Features Other


October 19, 2018

Laurie MacCaskill Partners with CancerConnect

By Anonymous User anonymous_user_10987

KETCHUM – LOS ANGELES: Laurie MacCaskill, a 12-year survivor of pancreatic cancer and former chair of the Pancreatic Cancer Action Network has announced a newly established partnership with Cancer Connect to support pancreatic cancer patients with information, support and inspiration. Cancer Connect, a national organization provides support and information to more than 1 million patients […]

View full entry

Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer


August 20, 2018

FDA Approves Lenvatinib for Treatment of Advanced Hepatocellular Cancer

By Anonymous User anonymous_user_10987

The U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). This approval was based on results from REFLECT, where LENVIMA demonstrated a proven treatment effect on overall survival as well as statistically significant superiority and clinically meaningful improvements in progression-free survival […]

View full entry

Tags: Liver Cancer, News Tips and Features, News Tips and Features Other


July 12, 2018

Cyramza Improves Survival in Poor-Prognosis Liver Cancer

By Anonymous User anonymous_user_10987

Andrew X. Zhu, MD, PhD, director of Liver Cancer Research at Massachusetts General Hospital presented new data at the 2018 World Congress on Gastrointestinal Cancer (WCGC) demonstrating that Cyramza (ramucirumab) significantly improves survival in a subset of patients with hepatocellular carcinoma (HCC) who have high levels of the plasma protein α-fetoprotein (AFP), which is associated […]

View full entry

Tags: cyramza, hepatocellular cancer treatment, Liver Cancer, News Tips and Features, News Tips and Features Other


CONDITIONS OF THE GI TRACT